SAO PAULO (Reuters) -Brazilian drugmaker Hypera said on Monday that shareholders executed an agreement by which a new control group now holds 53% of share capital. The new agreement is subject to approval by antitrust regulator CADE, Hypera said in a securities filing, adding that shareholders Joao Alves de Queiroz Filho, Alvaro Stainfeld Link, Maiorem […]
Health
Brazil’s Hypera announces new majority stakeholder group
Audio By Carbonatix
SAO PAULO (Reuters) -Brazilian drugmaker Hypera said on Monday that shareholders executed an agreement by which a new control group now holds 53% of share capital.
The new agreement is subject to approval by antitrust regulator CADE, Hypera said in a securities filing, adding that shareholders Joao Alves de Queiroz Filho, Alvaro Stainfeld Link, Maiorem S.A. de C.V. and Votorantim S.A are members of the new control group.
(Reporting by Isabel Teles; Editing by Kylie Madry)